Trials / Completed
CompletedNCT03042273
High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection
A Randomised, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of High Strength Cranberry (Pacran®) in Women With Recurrent Urinary Tract Infections (Cystitis)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Swisse Wellness Pty Ltd · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial is a Phase 2, multicenter, placebo-controlled, double-blind, parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry (500mg Pacran®) in preventing UTI (cystitis) in women with a history of recurrent UTI (rUTI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | High Strength Cranberry | Softgel capsule |
| DIETARY_SUPPLEMENT | Placebo | Soy oil to match High Strength Cranberry Softgel Capsule |
Timeline
- Start date
- 2017-05-15
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-02-03
- Last updated
- 2020-03-18
Locations
5 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT03042273. Inclusion in this directory is not an endorsement.